Cargando…
Observational study comparing pharmacoinvasive strategy with primary percutaneous coronary intervention in patients presenting with ST elevation myocardial infarction to a tertiary care centre in India
OBJECTIVE: The objective was to study whether the incidence of composite end points (mortality, cardiogenic shock and re-myocardial infarction [re-MI]) in pharmacoinvasive strategy was noninferior to primary percutaneous coronary intervention (PCI) in patients with ST-elevation myocardial infarction...
Autores principales: | Alex, AG, Lahiri, A, Devika, Geevar, T, George, OK |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Medknow Publications & Media Pvt Ltd
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5954818/ https://www.ncbi.nlm.nih.gov/pubmed/29067927 http://dx.doi.org/10.4103/jpgm.JPGM_766_16 |
Ejemplares similares
-
Primary PCI versus pharmacoinvasive strategy for ST elevation myocardial infarction
por: Helal, Ayman M., et al.
Publicado: (2018) -
Feasibility and efficacy of delayed pharmacoinvasive therapy for ST-elevation myocardial infarction
por: Sethi, Rishi, et al.
Publicado: (2023) -
Outcomes in ST-segment elevation myocardial infarction treated with primary percutaneous coronary intervention or pharmacoinvasive strategy in a Latin American country
por: Chacón-Diaz, Manuel, et al.
Publicado: (2022) -
Pharmacoinvasive Strategy vs Primary Percutaneous Coronary Intervention in Patients With ST-Elevation Myocardial Infarction: Results From a Study in Mexico City
por: Araiza-Garaygordobil, Diego, et al.
Publicado: (2020) -
Predictors of in-hospital mortality in patients with ST-segment elevation myocardial infarction undergoing pharmacoinvasive treatment
por: de Andrade Falcão, Felipe José, et al.
Publicado: (2013)